Cerus Corporation - Common Stock (CERS)

CERS stock results show that Cerus met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

U.S. stock futures were mixed this morning, with the Dow futures falling by around 10 points on Monday.

On Wednesday, Cathie Wood-led Ark Invest made a significant move by offloading shares of Block Inc (NYSE:SQ) amidst Bitcoin (CRYPTO: BTC) prices recovering.

Cerus reports results from the ReCePI Phase 3 trial for INTERCEPT Red Blood Cells, meeting the primary efficacy endpoint in cardiac surgery patients. The safety profile is also favorable. Expect FDA application in 2025.

On Wednesday, Cathie Wood-led Ark Invest made significant trades involving Coinbase Global Inc (NASDAQ:COIN) and Pinterest Inc (NYSE:PINS).

U.S. stocks were higher, with the Dow Jones index gaining more than 200 points on Wednesday.

Shares of United Natural Foods, Inc. (NYSE: UNFI) fell sharply during Wednesday’s session following second-quarter results.

CERS stock results show that Cerus beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.